Volume 24, Number 5—May 2018
Research Letter
Middle East Respiratory Syndrome Coronavirus Antibodies in Dromedary Camels, Bangladesh, 2015
Table
Characteristic | No. (%) camels | No. (%) positive for MERS-CoV, by laboratory test |
||||||
---|---|---|---|---|---|---|---|---|
rPCR (%) | ELISA (%, 95% CI) | ppNT (%, 95% CI) | ||||||
All camels | ||||||||
Location | ||||||||
Farm | 36 (56) | 0 | 6 (17, 6–33) | 5 (14, 5–29) | ||||
Market | 19 (35) | 0 | 11 (58, 34–80) | 12 (63, 38–84) | ||||
Origin | ||||||||
Imported | 31 (56) | 0 | 16 (52, 33–70) | 16 (52, 33–70) | ||||
Bangladesh | 24 (44) | 0 | 1 (4, 1–21) | 1 (4, 0–21) | ||||
Sex | ||||||||
M | 29 (53) | 0 | 6 (21, 8–40) | 7 (24, 10–44) | ||||
F | 26 (47) | 0 | 11 (42, 23–63) | 10 (38, 20–59) | ||||
Age group | ||||||||
Adult, >2 y | 44 (80) | 0 | 16 (36, 22–52) | 16 (36, 22–52) | ||||
Juvenile, <2 y | 11 (20) | 0 | 1 (9, 1–41) | 1 (9, 0–41) | ||||
Body condition | ||||||||
Poor | 19 (35) | 0 | 11 (58, 34–80) | 12 (63, 38–84) | ||||
Fair | 6 (11) | 0 | 1 (16, 1–64) | 0 | ||||
Good | 30 (55) | 0 | 5 (17, 1–35) | 5 (17, 06–35) | ||||
Upper respiratory signs | ||||||||
Yes | 2 (4) | 0 | 1 (50, 1–99) | 0 | ||||
No |
53 (96) |
0 |
16 (30, 18–44 |
17 (32, 20–46) |
||||
Farm camels | ||||||||
Age group | ||||||||
Adult, >2 y | 8 (22) | 0 | 0 | 0 | ||||
Juvenile, <2 y | 28 (78) | 0 | 6 (21, 8–41) | 5 (18, 6–37) | ||||
Sex | ||||||||
M | 18 (50) | 0 | 1 (6, 1–27) | 4 (22, 6–48) | ||||
F | 18 (50) | 0 | 5 (28, 10–53) | 1 (6, 1–27) | ||||
Origin | ||||||||
Bangladesh | 24 (67) | 0 | 1 (4, 1–21) | 1 (4, 1–21) | ||||
Imported |
12 (33) |
0 |
5 (42, 15–72) |
4 (33, 9–65) |
||||
Market camels | ||||||||
Age group | ||||||||
Adult, >2 y | 3 (16) | 0 | 1 (33, 1–90) | 1 (33, 1–90) | ||||
Juvenile, <2 y | 16 (84) | 0 | 10 (63, 35–85) | 11 (69, 41–89) | ||||
Sex | ||||||||
M | 11 (58) | 0 | 6 (75, 23–83) | 6 (55, 23–83) | ||||
F | 8 (42) | 0 | 5 (45, 24–91) | 6 (75, 35–97) | ||||
Origin | ||||||||
Bangladesh | 0 | 0 | 0 | 0 | ||||
Imported | 19 (100) | 0 | 11 (58, 34–80) | 12 (63, 38–84) |
*MERS-CoV, Middle East respiratory syndrome coronavirus; ppNT, pseudoparticle neutralization test; rPCR, real-time PCR.
Page created: April 17, 2018
Page updated: April 17, 2018
Page reviewed: April 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.